...
机译:联合治疗与Teladrevir用于慢性丙型肝炎病毒基因型1感染患者艾滋病毒随机试验
Johns Hopkins University School of Medicine 600 North Wolfe Street 1830 Building Baltimore MD;
University of Cincinnati College of Medicine 231 Albert Sabin Way Cincinnati OH 45267 United;
Mount Sinai School of Medicine 1468 Madison Avenue Annenberg 21-42 New York NY 10029 United;
Mahnke Garg and Rubin: Vertex Pharmaceuticals Incorporated 130 Waverly Street Cambridge MA;
Mahnke Garg and Rubin: Vertex Pharmaceuticals Incorporated 130 Waverly Street Cambridge MA;
Department of Medicine I Universit?tsklinikum Bonn Siegmund-Freudstr. 25 53105 Bonn Germany;
Cambridge Innovation Center One Broadway 14th Floor Cambridge MA 02142 United States;
Gilead Sciences 333 Lakeside Drive (300-132084) Foster City CA 94404 United States;
616 Vernon Way Burlingame CA 94010 United States;
Service des Maladies Infectieuses H?pital St. Antoine 184 Rue du Faubourg Saint-Antoine 75012;
16 Brighton Street Belmont MA 02478 United States;
16 Brighton Street Belmont MA 02478 United States;
16 Brighton Street Belmont MA 02478 United States;
Transgene 5 Cambridge Center Cambridge MA 02142 United States;
Department of Infectious Diseases Hospital Carlos III Calle Sinesio Delgado 10 Madrid 28029;
Vertex pharmaceuticals and janssen pharmaceuticals;
机译:替拉普韦联合治疗慢性丙型肝炎病毒基因型1感染艾滋病毒患者的一项随机试验
机译:Grazoprevir-Elbasvir联合疗法用于初治肝硬化和非肝硬化患者的慢性丙型肝炎病毒基因型1、4或6感染的随机试验
机译:达卡他韦联合Asunaprevir和Beclabuvir在慢性丙型肝炎病毒基因型4感染患者中的随机试验
机译:HCV / HIV与Peginterferon Alfa-2a(40KD)(Pegasys〜R)加上利韦韦林(Copegus〜R)在杏试验期间HCV / HIV CONOMENT患者持续病毒学反应(SVR)的可预测性
机译:利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
机译:Mericitabine和Boceprevir或Telaprevir与Peginterferon Alfa-2a加Ribavirin联合治疗慢性丙型肝炎基因1型感染和先前无效反应的患者:DYNAMO 1和DYNAMO 2随机研究
机译:达卡他韦联合asunaprevir和beclabuvir在慢性丙型肝炎病毒基因型4感染患者中的随机试验